Chase Sun

Established in 1996, Tianjin Chase Sun Pharmaceutical Co., Ltd. is a high-tech medicine and health industry group engaged in such fields as Chinese herb preparation, Chinese medicinal granule, synthetic drugs, biotech drugs, medical apparatus and internet-based therapy, and integrating investment, research and development, production and capital. Chase Sun has total assets valued at RMB 6.4 billion and a market value of RMB 20 billion, with 29 subordinate companies and more than 5,400 employees. Chase Sun listed at Shenzhen Stock Exchange as stock code 300026. In 2017 China Top 100 Pharmaceutical Industry Enterprises list ranked #75